Literature DB >> 8838025

Residence half-life of IgG administered topically to the mouse vagina.

J K Sherwood1, L Zeitlin, X Chen, K J Whaley, R A Cone, W M Saltzman.   

Abstract

Antibodies delivered directly to the vagina can provide passive immunoprotection against pregnancy and sexually transmitted disease. The duration of protection is limited by the residence time of the antibodies in the vagina; to our knowledge such residence times have not been reported. We investigated the time-course of disappearance of IgG delivered to the mouse vagina using three different methods to monitor the amount of administered IgG remaining in the vagina: gamma counting of 125I-IgG, viral neutralization of unlabeled monoclonal anti-herpes virus IgG2a, and ELISA of biotinylated IgG. The test IgG was delivered to the vagina in saline and recovered by lavage. All three methods yielded similar results, suggesting that the residence half-life is not significantly affected by the volume administered, phase of the estrous cycle, or labeling of IgG. In awake mice, a significant fraction of IgG disappeared with a relatively short half-life, (t1/2)alpha, of 0.7 +/- 0.1 h; but this rapid (alpha phase) decrease did not occur in anesthetized mice, suggesting that the movements of awake mice expel some of the test IgG-saline solution from the vagina. Over the next 25 h, the test IgG disappeared with a residence half-life, (t1/2)beta, of 5 +/- 2 h. We believe this slow elimination of IgG may depend on the rate that mucus secretions are shed from the vagina.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8838025     DOI: 10.1095/biolreprod54.1.264

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  17 in total

1.  Rapid transport of large polymeric nanoparticles in fresh undiluted human mucus.

Authors:  Samuel K Lai; D Elizabeth O'Hanlon; Suzanne Harrold; Stan T Man; Ying-Ying Wang; Richard Cone; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-23       Impact factor: 11.205

2.  Size-dependent biodistribution of thiol-organosilica nanoparticles and F4/80 protein expression in the genital tract of female mice after intravaginal administration.

Authors:  Aziz Awaad; Michihiro Nakamura
Journal:  Histochem Cell Biol       Date:  2021-03-03       Impact factor: 4.304

3.  Biodistribution and pharmacokinetics of dapivirine-loaded nanoparticles after vaginal delivery in mice.

Authors:  José das Neves; Francisca Araújo; Fernanda Andrade; Mansoor Amiji; Maria Fernanda Bahia; Bruno Sarmento
Journal:  Pharm Res       Date:  2014-01-22       Impact factor: 4.200

4.  Experimental gonococcal genital tract infection and opacity protein expression in estradiol-treated mice.

Authors:  A E Jerse
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

5.  In vivo distribution of surface-modified PLGA nanoparticles following intravaginal delivery.

Authors:  Yen Cu; Carmen J Booth; W Mark Saltzman
Journal:  J Control Release       Date:  2011-07-08       Impact factor: 9.776

Review 6.  Protein and oligonucleotide delivery systems for vaginal microbicides against viral STIs.

Authors:  Jill M Steinbach
Journal:  Cell Mol Life Sci       Date:  2014-10-17       Impact factor: 9.261

7.  Enhanced vaginal drug delivery through the use of hypotonic formulations that induce fluid uptake.

Authors:  Laura M Ensign; Timothy E Hoen; Katharina Maisel; Richard A Cone; Justin S Hanes
Journal:  Biomaterials       Date:  2013-06-13       Impact factor: 12.479

8.  Clinical trial considerations on male contraception and collection of pregnancy information from female partners.

Authors:  Maria Longauer Banholzer; Heinrich Buergin; Christoph Wandel; Georg Schmitt; Elmar Gocke; Richard Peck; Thomas Singer; Theresa Reynolds; Marie Mannino; Jonathan Deutsch; Lucette Doessegger
Journal:  J Transl Med       Date:  2012-06-21       Impact factor: 5.531

9.  Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loops.

Authors:  Jessica G Cole; Ann E Jerse
Journal:  PLoS One       Date:  2009-12-01       Impact factor: 3.240

10.  Nanoparticle transport from mouse vagina to adjacent lymph nodes.

Authors:  Byron Ballou; Susan K Andreko; Elvira Osuna-Highley; Michael McRaven; Tina Catalone; Marcel P Bruchez; Thomas J Hope; Mohamed E Labib
Journal:  PLoS One       Date:  2012-12-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.